持田製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/03/26 | 7,100 | 7,170 | 7,020 | 7,110 | -60 | -0.8% | 37,900 |
2018/03/23 | 7,320 | 7,340 | 7,170 | 7,170 | -220 | -3% | 36,500 |
2018/03/22 | 7,370 | 7,400 | 7,330 | 7,390 | +30 | +0.4% | 15,700 |
2018/03/20 | 7,350 | 7,380 | 7,320 | 7,360 | -50 | -0.7% | 26,700 |
2018/03/19 | 7,400 | 7,430 | 7,370 | 7,410 | -20 | -0.3% | 14,200 |
2018/03/16 | 7,520 | 7,540 | 7,430 | 7,430 | -90 | -1.2% | 18,300 |
2018/03/15 | 7,570 | 7,590 | 7,510 | 7,520 | -50 | -0.7% | 15,900 |
2018/03/14 | 7,540 | 7,600 | 7,510 | 7,570 | -40 | -0.5% | 12,200 |
2018/03/13 | 7,530 | 7,620 | 7,490 | 7,610 | +80 | +1.1% | 22,100 |
2018/03/12 | 7,570 | 7,580 | 7,500 | 7,530 | -20 | -0.3% | 16,300 |
2018/03/09 | 7,600 | 7,650 | 7,460 | 7,550 | +60 | +0.8% | 41,100 |
2018/03/08 | 7,500 | 7,550 | 7,460 | 7,490 | +50 | +0.7% | 22,100 |
2018/03/07 | 7,470 | 7,470 | 7,400 | 7,440 | -110 | -1.5% | 35,400 |
2018/03/06 | 7,560 | 7,640 | 7,530 | 7,550 | -10 | -0.1% | 26,000 |
2018/03/05 | 7,460 | 7,600 | 7,460 | 7,560 | +100 | +1.3% | 24,000 |
2018/03/02 | 7,540 | 7,540 | 7,430 | 7,460 | -130 | -1.7% | 27,500 |
2018/03/01 | 7,740 | 7,740 | 7,590 | 7,590 | -110 | -1.4% | 23,400 |
2018/02/28 | 7,750 | 7,790 | 7,690 | 7,700 | -50 | -0.6% | 33,100 |
2018/02/27 | 7,850 | 7,850 | 7,720 | 7,750 | -90 | -1.1% | 28,100 |
2018/02/26 | 7,790 | 7,860 | 7,780 | 7,840 | +130 | +1.7% | 13,900 |
2018/02/23 | 7,770 | 7,790 | 7,690 | 7,710 | -90 | -1.2% | 24,300 |
2018/02/22 | 7,700 | 7,840 | 7,680 | 7,800 | +70 | +0.9% | 26,900 |
2018/02/21 | 7,750 | 7,790 | 7,710 | 7,730 | -60 | -0.8% | 18,400 |
2018/02/20 | 7,750 | 7,850 | 7,750 | 7,790 | +40 | +0.5% | 15,500 |
2018/02/19 | 7,700 | 7,810 | 7,700 | 7,750 | +130 | +1.7% | 15,600 |
2018/02/16 | 7,570 | 7,660 | 7,570 | 7,620 | +60 | +0.8% | 26,700 |
2018/02/15 | 7,590 | 7,660 | 7,550 | 7,560 | -30 | -0.4% | 20,000 |
2018/02/14 | 7,650 | 7,680 | 7,570 | 7,590 | -60 | -0.8% | 26,400 |
2018/02/13 | 7,780 | 7,850 | 7,630 | 7,650 | -80 | -1% | 28,700 |
2018/02/09 | 7,720 | 7,750 | 7,640 | 7,730 | -170 | -2.2% | 36,100 |
2018/02/08 | 7,940 | 8,000 | 7,880 | 7,900 | -20 | -0.3% | 28,900 |
2018/02/07 | 8,070 | 8,190 | 7,910 | 7,920 | +10 | +0.1% | 44,800 |
2018/02/06 | 8,200 | 8,200 | 7,810 | 7,910 | -420 | -5% | 57,100 |
2018/02/05 | 8,280 | 8,380 | 8,200 | 8,330 | -130 | -1.5% | 33,300 |
2018/02/02 | 8,330 | 8,510 | 8,320 | 8,460 | -10 | -0.1% | 20,200 |
2018/02/01 | 8,230 | 8,510 | 8,230 | 8,470 | +90 | +1.1% | 20,700 |
2018/01/31 | 8,430 | 8,560 | 8,370 | 8,380 | -100 | -1.2% | 34,500 |
2018/01/30 | 8,490 | 8,550 | 8,460 | 8,480 | -20 | -0.2% | 22,500 |
2018/01/29 | 8,550 | 8,610 | 8,500 | 8,500 | -90 | -1% | 12,000 |
2018/01/26 | 8,590 | 8,630 | 8,560 | 8,590 | +90 | +1.1% | 18,100 |
2018/01/25 | 8,550 | 8,600 | 8,490 | 8,500 | -70 | -0.8% | 19,200 |
2018/01/24 | 8,490 | 8,580 | 8,490 | 8,570 | +20 | +0.2% | 13,400 |
2018/01/23 | 8,530 | 8,610 | 8,530 | 8,550 | +10 | +0.1% | 16,300 |
2018/01/22 | 8,430 | 8,560 | 8,430 | 8,540 | -30 | -0.4% | 19,000 |
2018/01/19 | 8,590 | 8,680 | 8,560 | 8,570 | -80 | -0.9% | 13,400 |
2018/01/18 | 8,800 | 8,810 | 8,650 | 8,650 | -150 | -1.7% | 26,900 |
2018/01/17 | 8,920 | 8,920 | 8,780 | 8,800 | -90 | -1% | 19,900 |
2018/01/16 | 8,920 | 8,920 | 8,870 | 8,890 | -10 | -0.1% | 12,500 |
2018/01/15 | 8,880 | 8,930 | 8,830 | 8,900 | +70 | +0.8% | 13,000 |
2018/01/12 | 8,860 | 8,940 | 8,780 | 8,830 | -110 | -1.2% | 36,000 |
1751~
1800
件表示中 / 3708件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
持田薬 | 294,000円 | +5.1% | -7.0% | 2.72% | 19.30倍 | 0.80倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
東和薬品 | 310,000円 | +7.9% | -3.3% | 2.58% | 8.62倍 | 0.89倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
ゼリア新薬 | 216,500円 | +3.1% | -6.5% | 2.22% | 10.05倍 | 1.07倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
杏林製薬 | 146,300円 | -2.4% | -52.3% | 3.90% | 17.51倍 | 0.62倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
栄研化 | 200,500円 | +4.1% | -3.1% | 2.89% | 17.59倍 | 1.53倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム